When a government minister returns from New York with a communiqué, the document’s value is not determined by the elegance of its language or the seniority of the signatories. It is determined by whether a nurse in Tamale has reliable medicines six months later, whether a community health worker in Ziguinchor receives a salary, whether a disease surveillance system in Lagos flags an outbreak before it crosses a border. That gap between diplomatic commitment and delivered service is the central governance failure haunting health policy across West Africa, and no amount of high-level engagement will close it without deliberate institutional architecture to do so.
The 81st session of the United Nations General Assembly offered African governments another opportunity to shape the global health agenda. Several West African states advanced positions on climate-resilient primary healthcare, pharmaceutical manufacturing, and community health systems. Ghana, Senegal, and Nigeria each carry specific institutional weight in these conversations, as anchor economies whose domestic health governance choices reverberate across the ECOWAS zone’s 400 million people. Yet the pattern that has defined African health diplomacy for two decades persists: commitments made abroad that remain structurally disconnected from the national plans, budget cycles, and accountability mechanisms that would give them operational meaning.
This is not a failure of ambition. It is a failure of institutional design, and West Africa’s regional frameworks are both part of the problem and the most credible vehicle for a solution.
ECOWAS has maintained a health policy framework since the 1980s, and the ECOWAS Health Organisation provides a formal mandate for regional coordination on disease surveillance, pharmaceutical regulation, and health systems strengthening. In practice, however, member states have treated health as a predominantly national competency, engaging regional institutions selectively and funding them inconsistently. The result is a coordination architecture that lacks the fiscal base, technical staff, and political authority to enforce the standards it nominally sets. When COVID-19 exposed the fragility of regional supply chains for personal protective equipment, oxygen, and vaccines, ECOWAS had no pre-positioned procurement mechanism capable of rapid collective response. Individual governments scrambled bilaterally, often paying premium prices for inferior products, while the institutional machinery designed for exactly this scenario remained on the margins.
The pharmaceutical manufacturing question crystallises the governance stakes most sharply. Africa currently produces less than 3 percent of the medicines it consumes, a dependency that the African Union’s Pharmaceutical Manufacturing Plan and the AfCFTA’s health annex are explicitly designed to address. Ghana’s Accra-based pharmaceutical sector, Senegal’s Institut Pasteur de Dakar, and Nigeria’s nascent vaccine manufacturing initiatives represent genuine industrial assets. But converting these assets into continental health security requires something that diplomatic statements alone cannot provide: enforceable technology transfer agreements, harmonised regulatory frameworks across ECOWAS member states, and long-term public procurement commitments that give manufacturers the demand certainty to justify capital investment.
Without regional procurement pooling, a Ghanaian manufacturer cannot price competitively against Indian or Chinese generics flooding fragmented national markets. Without regulatory harmonisation between the Food and Drugs Authority in Accra and its counterparts in Abidjan, Lagos, and Dakar, products approved in one jurisdiction face duplicative and expensive re-registration processes in neighbouring markets. The African Medicines Agency, established under the AU in 2021 and now in the process of operationalisation, is designed to address exactly this regulatory fragmentation. West African governments that champion pharmaceutical sovereignty at UNGA must simultaneously accelerate their ratification of the AMA treaty and fund its operations at the level the mandate requires.
Community health infrastructure presents a parallel governance challenge. Ghana’s Community Health Planning and Services programme, Senegal’s community health worker cadres, and Nigeria’s Primary Health Care Under One Roof initiative each represent serious domestic investments in the last-mile delivery architecture that converts health policy into household-level outcomes. The structural vulnerability these programmes share is financing: they depend disproportionately on donor project cycles that operate outside national budget systems, creating parallel administrative structures that erode rather than strengthen institutional capacity. When the Gates Foundation or USAID cycles out of a specific programme, the community health workers trained under it often have no absorption pathway into the national civil service, and the data systems built for the project are incompatible with national health information systems.
The governance remedy is not to reject international partnerships but to restructure their terms. West African finance ministries and health ministries must negotiate agreements that channel external resources through national treasury systems, align with national health sector plans, and include explicit capacity transfer timelines. Côte d’Ivoire’s experience with the Global Fund’s transition planning offers instructive precedent: the country negotiated a co-financing schedule that incrementally shifted domestic budget responsibility for HIV and malaria programmes over a defined period, building fiscal ownership rather than dependency. This model is replicable across the region, but it requires health ministries with sufficient technical capacity to negotiate on equal terms with multilateral and bilateral partners, which itself demands sustained investment in public financial management and health economics expertise within government.
Climate change is restructuring the epidemiological landscape in ways that expose another institutional gap. Sahel expansion is pushing malaria transmission zones northward into areas with no historical health infrastructure for vector control. Coastal flooding in Ghana’s Volta Region and Nigeria’s Niger Delta is contaminating water sources and driving cholera outbreaks. The ECOWAS Climate Change and Variability Policy provides a regional framework, but health sector integration into climate adaptation planning remains weak at both the national and regional levels. Climate financing instruments, including the Green Climate Fund and the Loss and Damage fund established at COP27, do not automatically direct resources toward health system resilience unless governments make explicit, technically grounded submissions. West African health ministries currently lack the dedicated climate-health units needed to develop and prosecute such submissions effectively.
Child nutrition data adds quantitative urgency to these institutional arguments. The ECOWAS region contains some of the world’s highest rates of stunting: in Niger, 47 percent of children under five are stunted; in Nigeria, the figure is approximately 37 percent; in Ghana, it stands near 19 percent but with significant regional variation that aggregate figures obscure. Stunting is not a medical anomaly. It is a governance outcome, reflecting the intersection of agricultural policy, social protection systems, maternal health services, and water and sanitation infrastructure. Addressing it requires cross-sectoral coordination mechanisms that most West African governments have designed on paper but not funded or staffed sufficiently to operate. International nutrition commitments made at UNGA or at Nutrition for Growth summits will not reduce stunting rates unless they are absorbed into national social protection frameworks with clear budget lines, implementation agencies, and monitoring systems that report publicly.
Accountability is ultimately the variable that separates health diplomacy from health governance. Citizens across West Africa have limited systematic access to information about what their governments commit to in international forums, what resources those commitments attract, and how those resources are deployed. Parliamentary health committees in Ghana and Nigeria have the formal mandate to scrutinise these questions but rarely receive the documentation needed to do so effectively. Civil society organisations working on health financing transparency, including those affiliated with the International Budget Partnership’s network in the region, have demonstrated that budget tracking can shift resource allocation when it generates public and legislative pressure. Governments that claim commitment to health sovereignty should publish, in accessible formats, the specific agreements signed at multilateral forums, the financing secured, and the domestic implementation plans attached to each commitment.
What West Africa’s health systems need from their governments’ international engagements is not more declarations of intent. It is the institutional plumbing that connects a signed agreement in New York to a functional laboratory in Kumasi, a paid community health worker in Kaolack, or a stocked pharmacy in Kano. That plumbing is built through regional regulatory harmonisation, domestically owned financing frameworks, cross-sectoral governance mechanisms, and accountability systems that give citizens the information to hold institutions to account. The diplomatic platform exists. The regional frameworks exist. The question is whether West African governments will invest the political capital and public resources needed to make them operational at the scale the region’s health burden demands.
